undamentalytics Newsletter

Aveanna Healthcare Holdings, Inc. income statement

In fiscal 2025, Aveanna Healthcare Holdings, Inc. reported revenue of $2.43bn, up 20.2% on the year before, operating income of $256m (a 10.5% margin) and net income of $225m, or $1.05 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Aveanna Healthcare Holdings, Inc.: income statement, annual
Fiscal year2019Dec 20192020Jan 20212021Jan 20222022Dec 20222023Dec 20232024Dec 20242025Jan 2026LTMJul 2026
Revenue1,3841,4951,6791,7881,8952,0252,4332,603
Gross profit419455542553595636810840
Selling, general and administrative228241297357361353374386
Operating income39−3−36−6428140256274
Interest expense928369108153157140125
Income before tax−75−52−114−664−1395107154
Income tax153−2−416−118−121
Net income−77−57−117−662−135−11225275
Diluted EPS−$0.56−$0.40−$0.69−$3.57−$0.71−$0.06$1.05$1.23
Diluted shares (average)137m141m171m186m190m193m215m223m
EBITDA5314−16−62122151267285

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AVAH vs HIMSAVAH vs CHEAVAH vs PRVA

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Aveanna Healthcare Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Aveanna Healthcare Holdings, Inc.